Persistent disparities of cervical cancer among American Indians/Alaska natives: Are we maximizing prevention tools?
Persistent disparities of cervical cancer among American Indians/Alaska natives: Are we maximizing prevention tools?
复制标题
美洲印第安人/阿拉斯加原住民之间宫颈癌的持续差异:我们是否最大限度地利用了预防工具?
DOI:
10.1016/j.ygyno.2022.11.007
复制
发表时间:
2023
影响因子:
4.7
通讯作者:
Tirumala,K
中科院分区:
文献类型:
--
作者:
Bruegl,AS;Emerson,J;Tirumala,K
BackgroundCervical cancer incidence and mortality disparities experienced by American Indian/Alaska Native (AI/AN) women have persisted for decades. Pap smear screening and HPV vaccination are powerful tools to prevent cervical cancer. We evaluated the utilization of these tools among AI/ANs living in the Pacific Northwest (PNW).MethodsThe Indian Health Service (IHS) National Data Warehouse's Epi Data Mart was analyzed using all healthcare visits from 2010 to 2020 from IHS, Tribal, and Urban Indian clinics in the PNW. Women ages 21–64 were included and considered up-to-date on pap smears if they had either cytology within 3 years or cytology with HPV testing within 5 years of the most recent clinical encounter. HPV vaccination rates for both sexes were calculated for individuals ages 9–26. HPV vaccination was considered complete if: two vaccines were received prior to age 15 or after three vaccinations if initiated after age 15.FindingsCervical cancer screening rates are below the national average of 73.5% ranging between 57.1% - 65.0%. Sub-analysis of age groups shows substantially lower rates of up-to-date pap smear screening in the 50–64 age group. HPV vaccination rates have increased over time for both sexes across all age groups. However, the current vaccination rate of 58.6% is well below the Healthy People 2030 goal of 84.3%.InterpretationCervical cancer screening and HPV vaccination are the cornerstones of cervical cancer prevention and early detection. These tools are underutilized and public health efforts can be strengthened to improve cervical cancer disparities in AI/AN women.FundingAuthor ASB: Funding for this project has been provided through the Robert Wood Johnson Foundation Harold Amos Minority Faculty Development Grant and the National Cancer Institute K08 Mentored Clinical Scientist Development Award.
登录
查看更多内容
DOI:
--
发表时间:
1987
期刊:
The Journal of biological chemistry
影响因子:
--
作者:
Daniel,TO;Gibbs,VC;Milfay,DF;Williams,LT
通讯作者:
Williams,LT
DOI:
--
发表时间:
1987
期刊:
The American journal of pathology
影响因子:
--
作者:
T. Collins;J. Pober;M. Gimbrone;A. Hammacher;C. Betsholtz;B. Westermark;C. Heldin
通讯作者:
T. Collins;J. Pober;M. Gimbrone;A. Hammacher;C. Betsholtz;B. Westermark;C. Heldin
DOI:
10.1152/ajplung.1989.257.2.l65
发表时间:
1989
期刊:
The American journal of physiology
影响因子:
--
作者:
Albelda,SM;Elias,JA;Levine,EM;Kern,JA
通讯作者:
Kern,JA
DOI:
--
发表时间:
1988
期刊:
The Journal of biological chemistry
影响因子:
--
作者:
Kavanaugh,WM;Harsh4th,GR;Starksen,NF;Rocco,CM;Williams,LT
通讯作者:
Williams,LT
DOI:
--
发表时间:
1990
期刊:
The Journal of biological chemistry
影响因子:
--
作者:
Gay,CG;Winkles,JA
通讯作者:
Winkles,JA